M.Pharma or Ph.D. in any branch of Life Sciences or Biotechnology with at least two peer-reviewed international publication in Science Citation indexed; experience in molecular biology related techniques including PCR, recombinant DNA cloning techniques, plant transformation, and library preparation methodologies for NGS.
Define, organize, plan and execute analytical activities and materials characterization of pharmaceutical injectables in compliance with current international/regional/national regulations with the support of senior colleagues and team members.
Expertise in Molecular Biology, Cell Biology, Structural biology, Immunology. The candidate should also be familiar with studying Protein- small molecule interaction, Tissue culture techniques, animal handling, enzymatic assays, Immune phenotyping.
Ph.D, MD, MS, MDS or MVSc, ME, M.Pharm, M.Tech equivalent degree Pragmatic strategies for the delivery of phytodrugs across BBB through plant derived exosomes for the management of neuroinflammatory diseases.
The institute was founded in 1985 as the ‘Biotechnology Centre’ of Indian Agricultural Research Institute (IARI) for molecular biology and biotechnology research in crop plants. The prescience of the role of biotechnology in agriculture led to a bigger responsibility for this centre and it was elevated as National Research Centre on Plant Biotechnology in the year 1993 (Now NIPB).
National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under the Department of Biotechnology, Government of India. NABI aims at catalysing the transformation of the Agri-food sector in India by being a nodal organization for knowledge generation and translational science leading to value-added products based on Agri-Food biotech innovations for improved household nutritional security.
Syri Research previously known as Thame Laboratories Licensed Medicines Division is one of the Leading Pharmaceutical Companies in the UK specialising in the development, licensing, manufacture and marketing of liquid medicines. Established during 2004 in Ruislip, West London; SyriMed with the experience from the development and manufacture of unlicensed medicines started in 2014 to obtain marketing authorisations for its unlicensed Liquid medicines.ln May 2020, SyriMed held over 50 marketing authorisations for liquid medicines within the UK.